These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 31247891)

  • 1. Cathepsin L Inhibitors with Activity against the Liver Fluke Identified From a Focus Library of Quinoxaline 1,4-di-
    Ferraro F; Merlino A; Gil J; Cerecetto H; Corvo I; Cabrera M
    Molecules; 2019 Jun; 24(13):. PubMed ID: 31247891
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of Chalcones as Fasciola hepatica Cathepsin L Inhibitors Using a Comprehensive Experimental and Computational Approach.
    Ferraro F; Merlino A; Dell Oca N; Gil J; Tort JF; Gonzalez M; Cerecetto H; Cabrera M; Corvo I
    PLoS Negl Trop Dis; 2016 Jul; 10(7):e0004834. PubMed ID: 27463369
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insights into the Interactions of Fasciola hepatica Cathepsin L3 with a Substrate and Potential Novel Inhibitors through In Silico Approaches.
    Hernández Alvarez L; Naranjo Feliciano D; Hernández González JE; Soares RO; Barreto Gomes DE; Pascutti PG
    PLoS Negl Trop Dis; 2015 May; 9(5):e0003759. PubMed ID: 25978322
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization and differential expression of cathepsin L3 alleles from Fasciola hepatica.
    Zawistowska-Deniziak A; Wasyl K; Norbury LJ; Wesołowska A; Bień J; Grodzik M; Wiśniewski M; Bąska P; Wędrychowicz H
    Mol Biochem Parasitol; 2013 Jul; 190(1):27-37. PubMed ID: 23770026
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of the Fasciola hepatica newly excysted juvenile cathepsin L3 (FhCL3) by its propeptide: a proposed 'clamp-like' mechanism of binding and inhibition.
    Pritsch IC; Tikhonova IG; Jewhurst HL; Drysdale O; Cwiklinski K; Molento MB; Dalton JP; Verissimo CM
    BMC Mol Cell Biol; 2020 Dec; 21(1):90. PubMed ID: 33287692
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fasciola hepatica: characterization and cloning of the major cathepsin B protease secreted by newly excysted juvenile liver fluke.
    Wilson LR; Good RT; Panaccio M; Wijffels GL; Sandeman RM; Spithill TW
    Exp Parasitol; 1998 Feb; 88(2):85-94. PubMed ID: 9538862
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Unexpected Activity of a Novel Kunitz-type Inhibitor: INHIBITION OF CYSTEINE PROTEASES BUT NOT SERINE PROTEASES.
    Smith D; Tikhonova IG; Jewhurst HL; Drysdale OC; Dvořák J; Robinson MW; Cwiklinski K; Dalton JP
    J Biol Chem; 2016 Sep; 291(37):19220-34. PubMed ID: 27422822
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early immunodiagnosis of fasciolosis in ruminants using recombinant Fasciola hepatica cathepsin L-like protease.
    Cornelissen JB; Gaasenbeek CP; Borgsteede FH; Holland WG; Harmsen MM; Boersma WJ
    Int J Parasitol; 2001 May; 31(7):728-37. PubMed ID: 11336755
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Flavonoid-quinoxaline Hybrid Compounds as Cathepsin Inhibitors Against Fascioliasis.
    Ferraro F; Merlino A; Gil J; Pérez-Silanes S; Corvo I; Cabrera M
    ChemMedChem; 2024 Jun; ():e202400305. PubMed ID: 38871654
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vaccination against Fasciola hepatica using cathepsin L3 and B3 proteases delivered alone or in combination.
    Wesołowska A; Basałaj K; Norbury LJ; Sielicka A; Wędrychowicz H; Zawistowska-Deniziak A
    Vet Parasitol; 2018 Jan; 250():15-21. PubMed ID: 29329618
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Collagenolytic activities of the major secreted cathepsin L peptidases involved in the virulence of the helminth pathogen, Fasciola hepatica.
    Robinson MW; Corvo I; Jones PM; George AM; Padula MP; To J; Cancela M; Rinaldi G; Tort JF; Roche L; Dalton JP
    PLoS Negl Trop Dis; 2011 Apr; 5(4):e1012. PubMed ID: 21483711
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibody recognition of cathepsin L1-derived peptides in Fasciola hepatica-infected and/or vaccinated cattle and identification of protective linear B-cell epitopes.
    Garza-Cuartero L; Geurden T; Mahan SM; Hardham JM; Dalton JP; Mulcahy G
    Vaccine; 2018 Feb; 36(7):958-968. PubMed ID: 29373193
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of thioredoxin glutathione reductase inhibitors that kill cestode and trematode parasites.
    Ross F; Hernández P; Porcal W; López GV; Cerecetto H; González M; Basika T; Carmona C; Fló M; Maggioli G; Bonilla M; Gladyshev VN; Boiani M; Salinas G
    PLoS One; 2012; 7(4):e35033. PubMed ID: 22536349
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fasciola hepatica cathepsin L-like proteases: biology, function, and potential in the development of first generation liver fluke vaccines.
    Dalton JP; Neill SO; Stack C; Collins P; Walshe A; Sekiya M; Doyle S; Mulcahy G; Hoyle D; Khaznadji E; Moiré N; Brennan G; Mousley A; Kreshchenko N; Maule AG; Donnelly SM
    Int J Parasitol; 2003 Sep; 33(11):1173-81. PubMed ID: 13678633
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fasciola hepatica: a comparative survey of adult fluke resistance to triclabendazole, nitroxynil and closantel on selected upland and lowland sheep farms in Northern Ireland using faecal egg counting, coproantigen ELISA testing and fluke histology.
    Hanna RE; McMahon C; Ellison S; Edgar HW; Kajugu PE; Gordon A; Irwin D; Barley JP; Malone FE; Brennan GP; Fairweather I
    Vet Parasitol; 2015 Jan; 207(1-2):34-43. PubMed ID: 25529143
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A major cathepsin B protease from the liver fluke Fasciola hepatica has atypical active site features and a potential role in the digestive tract of newly excysted juvenile parasites.
    Beckham SA; Piedrafita D; Phillips CI; Samarawickrema N; Law RH; Smooker PM; Quinsey NS; Irving JA; Greenwood D; Verhelst SH; Bogyo M; Turk B; Coetzer TH; Wijeyewickrema LC; Spithill TW; Pike RN
    Int J Biochem Cell Biol; 2009 Jul; 41(7):1601-12. PubMed ID: 19401154
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The major cathepsin L secreted by the invasive juvenile Fasciola hepatica prefers proline in the S2 subsite and can cleave collagen.
    Corvo I; Cancela M; Cappetta M; Pi-Denis N; Tort JF; Roche L
    Mol Biochem Parasitol; 2009 Sep; 167(1):41-7. PubMed ID: 19383516
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence for high genetic diversity of NAD1 and COX1 mitochondrial haplotypes among triclabendazole resistant and susceptible populations and field isolates of Fasciola hepatica (liver fluke) in Australia.
    Elliott T; Muller A; Brockwell Y; Murphy N; Grillo V; Toet HM; Anderson G; Sangster N; Spithill TW
    Vet Parasitol; 2014 Feb; 200(1-2):90-6. PubMed ID: 24360656
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Production and processing of a recombinant Fasciola hepatica cathepsin B-like enzyme (FhcatB1) reveals potential processing mechanisms in the parasite.
    Beckham SA; Law RH; Smooker PM; Quinsey NS; Caffrey CR; McKerrow JH; Pike RN; Spithill TW
    Biol Chem; 2006 Aug; 387(8):1053-61. PubMed ID: 16895475
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional characterization of single-domain cystatin-like cysteine proteinase inhibitors expressed by the trematode Fasciola hepatica.
    Cancela M; Corvo I; DA Silva E; Teichmann A; Roche L; Díaz A; Tort JF; Ferreira HB; Zaha A
    Parasitology; 2017 Nov; 144(13):1695-1707. PubMed ID: 28697819
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.